Hikma Pharmaceuticals (HKMPF)
PNK: HKMPF
· Real-Time Price · USD
26.93
0.73 (2.80%)
At close: May 07, 2025, 12:33 PM
Hikma Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 188M | 236M | 205M | 272M | 270M | 371M | 426M | 322M |
Short-Term Investments | 25M | 24M | 24M | 22M | 22M | 22M | 24M | 24M |
Long-Term Investments | 61.94M | 63M | 65M | 51M | 52M | 52M | 46M | 36M |
Other Long-Term Assets | 326.06M | 268M | 48M | -200M | -192M | -151M | -183M | -208M |
Receivables | 905M | 937M | 789M | 846M | 777M | 784M | 781M | 693M |
Inventory | 986M | 936M | 891M | 859M | 776M | 765M | 695M | 736M |
Other Current Assets | 86M | 71M | 119M | 92M | 80M | 122M | 103M | 102M |
Total Current Assets | 2.26B | 2.29B | 2.1B | 2.18B | 2B | 2.14B | 2.09B | 1.96B |
Property-Plant & Equipment | 1.33B | 1.14B | 1.14B | 1.09B | 1.08B | 1.13B | 1.15B | 1.06B |
Goodwill & Intangibles | 1.16B | 1.09B | 1.1B | 1.08B | 1.12B | 1.25B | 892M | 906M |
Total Long-Term Assets | 2.87B | 2.56B | 2.58B | 2.22B | 2.26B | 2.44B | 2.08B | 2B |
Total Assets | 5.13B | 4.85B | 4.68B | 4.62B | 4.47B | 4.75B | 4.37B | 4.18B |
Account Payables | 358M | 541M | 309M | 505M | 291M | 255M | 262M | 226M |
Deferred Revenue | n/a | n/a | 226M | -221M | -148M | -137M | -121M | -181M |
Short-Term Debt | 642M | 206M | 150M | 211M | 139M | 128M | 112M | 172M |
Other Current Liabilities | 528M | 486M | 481M | 322M | 366M | 342M | 328M | 308M |
Total Current Liabilities | 1.98B | 1.38B | 1.34B | 1.22B | 1.08B | 1.01B | 1.02B | 960M |
Long-Term Debt | 607M | 1.02B | 975M | 1.03B | 1.07B | 1.34B | 651M | 676M |
Other Long-Term Liabilities | 133.03M | 106M | 95M | -59M | -61M | -74M | -74M | -75M |
Total Long-Term Liabilities | 834M | 1.17B | 1.13B | 1.03B | 1.07B | 1.34B | 651M | 676M |
Total Liabilities | 2.81B | 2.55B | 2.47B | 2.42B | 2.32B | 2.56B | 1.91B | 1.88B |
Total Debt | 1.31B | 1.28B | 1.19B | 1.31B | 1.28B | 1.55B | 846M | 932M |
Common Stock | 40M | 40M | 40M | 40M | 40M | 41M | 42M | 41M |
Retained Earnings | 2.36B | 2.29B | 2.16B | 2.15B | 2.09B | 2.11B | 2.19B | 2.03B |
Comprehensive Income | n/a | -323M | -282M | -279M | -279M | -254M | -60M | -65M |
Shareholders Equity | 2.31B | 2.29B | 2.2B | 2.19B | 2.13B | 2.18B | 2.45B | 2.29B |
Total Investments | 87M | 87M | 113M | 73M | 74M | 74M | 70M | 60M |